Inhibition of rabies virus propagation in mouse neuroblastoma cells by an intrabody against the viral phosphoprotein

Antiviral Research

Volumn 91, Issue 1, 2011, Pages 64-71

  Kaku, Yoshihiro ^a   Noguchi, Akira ^a   Hotta, Kozue ^a   Yamada, Akio ^a   Inoue, Satoshi ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Intrabody; Intracellular immunization; Phosphoprotein; Rabies; ScFv

Indexed keywords

SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; VIRUS PHOSPHOPROTEIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOPLASM; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; IMMUNOPRECIPITATION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PHAGE DISPLAY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RABIES VIRUS; VIRUS INHIBITION; WESTERN BLOTTING;

ANIMALS; ANTIBODY SPECIFICITY; CELL LINE, TUMOR; CYTOPLASM; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENE EXPRESSION; IMMUNOPRECIPITATION; INTRACELLULAR SPACE; MICE; NEUROBLASTOMA; PHOSPHOPROTEINS; POST-EXPOSURE PROPHYLAXIS; RABIES VIRUS; SINGLE-CHAIN ANTIBODIES; VIRAL PROTEINS; VIRUS REPLICATION;

RABIES VIRUS;

EID: 79957557272     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2011.04.016     Document Type: Article

References (30)

1. Baltimore D. Gene therapy. Intracellular immunization. Nature 1988, 335:395-396.
2. Blondel D., Regad T., Poisson N., Pavie B., Harper F., Pandolfi P.P., De Thé H., Chelbi-Alix M.K. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 2002, 21:7957-7970.
3. Brandao P.E., Castilho J.G., Fahl W., Carnieli P., Oliveira Rde N., Macedo C.I., Carrieri M.L., Kotait I. Short-interfering RNAs as antivirals against rabies. Braz. J. Infect. Dis. 2007, 11:224-225.
4. Cao T., Heng B.C. Intracellular antibodies (intrabodies) versus RNA interference for therapeutic applications. Ann. Clin. Lab. Sci. 2005, 35:227-229.
5. Castel G., Chtéoui M., Caignard G., Préhaud C., Méhouas S., Réal E., Jallet C., Jacob Y., Ruigrok R.W.H., Tordo N. Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity. J. Virol. 2009, 83:10808-10820.
6. Chenik M., Chebli K., Gaudin Y., Blondel D. In vivo interaction of rabies virus phosphoprotein (P) and nucleoprotein (N): existence of two N-binding sites on P protein. J. Gen. Virol. 1994, 75:2889-2896.
7. Chenik M., Schnell M., Conzelmann K.K., Blondel D. Mapping the interacting domains between the rabies virus polymerase and phosphoprotein. J. Virol. 1998, 72:1925-1930.
8. Corte-Real S., Collins C., Aires da Silva F., Simas J.P., Barbas C.F., Chang Y., Moore P., Goncalves J. Intrabodies targeting the Kaposi sarcoma-associated herpesvirus latency antigen inhibit viral persistence in lymphoma cells. Blood 2005, 106:3797-3802.
9. Dykxhoorn D.M., Novina C.D., Sharp P.A. Killing the messenger: short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol. 2003, 4:457-467.
10. Gerard F.C.A., Ribeiro E.D.A., Leyrat C., Ivanov I., Blondel D., Longhi S., Ruigrok R.W.H., Jamin M. Modular organization of rabies virus phosphoprotein. J. Mol. Biol. 2009, 388:978-996.
11. Goncalves J., Silva F., Freitas-Vieira A., Santa-Marta M., Malhó R., Yang X., Gabuzda D., Barbas C. Functional neutralization of HIV-1 Vif protein by intracellular immunization inhibits reverse transcription and viral replication. J. Biol. Chem. 2002, 277:32036-32045.
12. Hemachudha T., Sunsaneewitayakul B., Desudchit T., Suankratay C., Sittipunt C., Wacharapluesadee S., Khawplod P., Wilde H., Jackson A.C. Failure of therapeutic coma and ketamine for therapy of human rabies. J. Neurovirol. 2006, 12:407-409.
13. Israsena N., Supavonwong P., Ratanasetyuth N., Khawplod P., Hemachudha T. Inhibition of rabies virus replication by multiple artificial microRNAs. Antiviral Res. 2009, 84:76-83.
14. Jiang W., Venugopal K., Gould E.A. Intracellular interference of tick-borne flavivirus infection by using a single-chain antibody fragment delivered by recombinant Sindbis virus. J. Virol. 1995, 69:1044-1049.
15. Karthe J., Tessmann K., Li J., Machida R., Daleman M., Häussinger D., Heintges T. Specific targeting of hepatitis C virus core protein by an intracellular single-chain antibody of human origin. Hepatology 2008, 48:702-712.
16. Kojima A., Yasuda A., Asanuma H., Ishikawa T., Takamizawa A., Yasui K., Kurata T. Stable high-producer cell clone expressing virus-like particles of the Japanese encephalitis virus e protein for a second-generation subunit vaccine. J. Virol. 2003, 77:8745-8755.
17. Lahaye X., Vidy A., Pomier C., Obiang L., Harper F., Gaudin Y., Blondel D. Functional characterization of Negri bodies (NBs) in rabies virus-infected cells: evidence that NBs are sites of viral transcription and replication. J. Virol. 2009, 83:7948-7958.
18. Marasco W.A. Intrabodies: turning the humoral immune system outside in for intracellular immunization. Gene Ther. 1997, 4:11-15.
19. Motoi Y., Inoue S., Hatta H., Sato K., Morimoto K., Yamada A. Detection of rabies-specific antigens by egg yolk antibody (IgY) to the recombinant rabies virus proteins produced in Escherichia coli. Jpn. J. Infect. Dis. 2005, 58:115-118.
20. Nawtaisong P., Keith J., Fraser T., Balaraman V., Kolokoltsov A., Davey R.A., Higgs S., Mohammed A., Rongsriyam Y., Komalamisra N., Fraser M.J. Effective suppression of Dengue fever virus in mosquito cell cultures using retroviral transduction of hammerhead ribozymes targeting the viral genome. Virol. J. 2009, 6:73.
21. Nigg A.J., Walker P.L. Overview, prevention, and treatment of rabies. Pharmacotherapy 2009, 29:1182-1195.
22. Ramm K., Gehrig P., Plückthun A. Removal of the conserved disulfide bridges from the scFv fragment of an antibody: effects on folding kinetics and aggregation. J. Mol. Biol. 1999, 290:535-546.
23. Reed L., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938, 27:493-497.
24. Schnell M.J., McGettigan J.P., Wirblich C., Papaneri A. The cell biology of rabies virus: using stealth to reach the brain. Nat. Rev. Microbiol. 2010, 8:51-61.
25. Stein C.A., Hansen J.B., Lai J., Wu S., Voskresenskiy A., Høg A., Worm J., Hedtjärn M., Souleimanian N., Miller P., Soifer H.S., Castanotto D., Benimetskaya L., Ørum H., Koch T. Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents. Nucleic Acids Res. 2010, 38:e3.
26. Vascotto F., Campagna M., Visintin M., Cattaneo A., Burrone O.R. Effects of intrabodies specific for rotavirus NSP5 during the virus replicative cycle. J. Gen. Virol. 2004, 85:3285-3290.
27. Vidy A., El Bougrini J., Chelbi-Alix M.K., Blondel D. The nucleocytoplasmic rabies virus P protein counteracts interferon signaling by inhibiting both nuclear accumulation and DNA binding of STAT1. J. Virol. 2007, 81:4255-4263.
28. Willoughby R.E., Tieves K.S., Hoffman G.M., Ghanayem N.S., Amlie-Lefond C.M., Schwabe M.J., Chusid M.J., Rupprecht C.E. Survival after treatment of rabies with induction of coma. N. Engl. J. Med. 2005, 352:2508-2514.
29. Wörn A., Plückthun A. Stability engineering of antibody single-chain Fv fragments. J. Mol. Biol. 2001, 305:989-1010.
30. Yamamoto M., Hayashi N., Takehara T., Ueda K., Mita E., Tatsumi T., Sasaki Y., Kasahara A., Hori M. Intracellular single-chain antibody against hepatitis B virus core protein inhibits the replication of hepatitis B virus in cultured cells. Hepatology 1999, 30:300-307.